Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • HELICOS BIOSCIENCES CORP Financial Overview

  • Income Statement: HLCS

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 808,000.00 582,000.00 226,000.00 27.97%
    Gross Profit -1.73 M -1.01 M -724,000.00 41.85%
    Net Income Before Extra Items/Preferred Div -45.65 M -36.80 M -8.85 M 19.38%
    Operating Income -43.96 M -38.49 M -5.47 M 12.44%
  • Cash Flow: HLCS

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 14.00 M 76.28 M -62.29 M -445.09%
    Net Cash Flow - Investing 2.66 M 1.39 M 1.28 M 47.90%
    Net Cash Flow/Operating Activities -44.30 M -32.80 M -11.50 M 25.95%
  • Balance Sheet: HLCS

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 31.46 M 59.21 M -27.75 M -88.20%
    Total Liabilities 10.96 M 15.77 M -4.81 M -43.93%
    Shareholders Equity 20.50 M 43.44 M -22.94 M -111.87%
  • Key Ratios / Statistics: HLCS

    • Valuation

      Price/Earnings (TTM) -0.19
      Price/Sales (TTM) 10.51
      Price/Book (MRQ) 2.87
      Price/Cash Flow (TTM) -2.57
    • Profitability

      Gross Margin -214.11
      Operating Margin -5,440.10
      Profit Margin -5,649.88
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.15
      Current Ratio (MRQ) 2.76
      Long Term Debt-to-Equity (MRQ) 33.90
    • Management Effectiveness

      Return on Equity (TTM) -175.62
      Return on Assets (TTM) -99.80
      Return on Investments (TTM) -105.57